The partnership supports Bhutan’s aim to advance and invest in sustainable building materials like mass timber and bamboo, to enhance construction at home and abroad. Avant Wood’s TMTM technology will ...

Dallas, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Parker Seminars , the world’s largest and most influential chiropractic and healthcare conference, announced today that Parker Seminars Las Vegas 2026 ...

Achmea selected eGain to empower 21,000 users across their organization, including 8,225 Contact Center Users and 12,750 Enterprise Users, with an AI Agent license for each user. This comprehensive ...

DARPA (Defense Advanced Research Projects Agency), and federal agency requirements through the development of secure, defense-oriented artificial intelligence systems enhanced by quantum computing ...

Wuthering Waves’ Most Significant Post-Launch Update to Date Begins an Epic Sci-Fi Romance and Features New Resonators, Content, Improvements, and More ...

BEIJING, Dec. 18, 2025 (GLOBE NEWSWIRE) -- China on Thursday launched island-wide special customs operations in south China's Hainan Free Trade Port (FTP), the world's largest FTP by area, allowing ...

Liom, a pioneer in non-invasive biomarker monitoring and the developer of the world’s first non-invasive glucose-monitoring wearable, today announced a CHF 13 million extension of its Series A ...

Allego and Mitiska REIM accelerate rollout of EV infrastructure at strategic retail locations ...

VICTORIA, Seychelles, Dec. 18, 2025 (GLOBE NEWSWIRE) -- BitMEX , one of the safest crypto exchanges, announced today the launch of its Year End Gala , allowing traders to compete for their share of ...

Numab to receive milestone payment. Boehringer Ingelheim has advanced its novel multi-specific antibody for retinal diseases resulting from a collaboration with Numab into preclin ...

NAT has today entered into firm agreements to sell two suezmax tankers (2004 and 2005-built) at a net price of $50 million for both vessels, improving our cash position correspondingly.

Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer’s disease. Clear and near-term value inflection point ...